Beyond Intellectual Property: Why Is Generic Treatment for HCV Still So Hard to Get
By Joelle Dountio Ofimboudem and Sara Helena Gaspar Background Intellectual property is a major barrier to access to medicines worldwide because it creates corporate monopolies that restrict supply, keep prices high, and prevent people from accessing innovative health products. However,…
Misinformation and Vaccine Preparedness: The Case for Digital Advocacy
By Erin McConnell A special thanks to Abraham Johnson, for contributing to an earlier draft of this piece Hesitancy around immunization has such deep historical roots that it predates the first vaccine. Before the term “anti-vaccine” was coined in the…
How Rising Anti-LGBTQ Sentiment Harms Public Health
By Kendall Martinez-Wright, Elizabeth Lovinger, and De’Ashia Lee Many people recognize advances the LGBTQ+ community has made in the United States and other countries, including the freedom to marry their partners, sexual orientation and gender identity protections, and the fact…
Are We There Yet? TB Preventive Treatment Beyond TB/HIV Integration
By Lynette Mabote-Eyde and Mike Frick Too often, major scientific advancements against tuberculosis (TB) get lost on the long and winding road of policy translation into practice. TB preventive treatment (TPT) has faced decades of dislocation between progressive global World…
TAGline October 2023
Translating Scientific Research from Labs to Lives
By Natalie Shure In the years since I developed drug-resistant tuberculosis (DR-TB) in 2010, the field has welcomed several scientific advances that would have fundamentally changed my experience of living with the disease. For one thing, my two- year treatment…
TAGline November 2022
Introducing 1/4/6×24: A Campaign That Draws Inspiration from the Past to Change the Trajectory of the Future Fight to End Tuberculosis
By Lindsay McKenna, Mike Frick, and Mark Harrington At the 24th International AIDS Conference in Montreal this summer, TAG, Partners In Health (PIH), and Médecins Sans Frontières (MSF) launched the 1/4/6x24 Campaign to accelerate equitable global uptake of newly discovered…
Community Representation in HIV Research: From Study Volunteers to Investigators
By Cheriko A. Boone, Abraham Johnson, and Richard Jefferys In a 1989 article by Dr. Anthony Fauci, “AIDS — Challenges to Basic and Clinical Biomedical Research” — which preceded Treatment Action Group’s founding by just a few years — he…